ABSTRACT
OBJECTIVES To determine risk factors for death in patients with COVID-19 admitted to the main public sector hospital in Somalia and identify interventions contributing to improved clinical outcome in a low-resource and fragile setting.
SETTING Main public sector tertiary hospital in Mogadishu, Somalia.
PARTICIPANTS All 131 laboratory-confirmed COVID-19 patients admitted to the main public tertiary hospital in Somalia between 30 March and 12 June 2020.
MAIN OUTCOME MEASURES We extracted demographic and clinical data from hospital records of all 131 COVID-19 patients admitted to hospital until their death or recovery. We used Kaplan–Meier statistics to estimate survival probabilities and the log-rank test to assess significant differences in survival between groups. We used the Cox proportional hazard model to estimate likelihood of death and assess the effect of risk factors on survival.
RESULTS Of the 131 patients, 52 (40%) died in the hospital and 79 (60%) survived to discharge. The factors independently associated with increased risk of in-hospital death were: age ≥ 60 years – survival probability on day 21 in patients < 60 years was 0.789 (95% confidence interval (CI): 0.658–0.874) compared with 0.339 (95% CI: 0.205–0.478) in patients ≥ 60 years; cardiovascular disease (survival probability 0.478 (95% CI: 0.332–0.610) in patients with cardiovascular disease compared with 0.719 (95% CI: 0.601–0.807) in patients without cardiovascular disease); and non-invasive ventilation on admission – patients who were not ventilated were significantly more likely to survive than those who were (P < 0.001).
CONCLUSION Our study, which includes the largest cohort of COVID-19 patients admitted to a single hospital in a sub-Saharan African country, confirms that underlying conditions and age are associated with increased risk of in-hospital death in patients with COVID-19. Our results show the advantage of medical oxygen over non-invasive ventilation in the treatment of patients with severe COVID-19 symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Somali Federal Republic, Ministry of Health and Human Services, Research and Ethics Review Committee, Ethical Approval Reference number: MOH&H/DGO/0622/July/2020 Director of Policy and Planning Tel +252612375800, email dg@moh.gov.so
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
the study data will be available from the WHO country office
